tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196
Hong Kong Market
2196
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports

Shanghai Fosun Pharmaceutical (Group) Co (2196) Financial Statements

5 Followers

Shanghai Fosun Pharmaceutical (Group) Co Financial Overview

Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently HK$75.74B. The company's EPS TTM is HK$0.3643874976; its P/E ratio is 14.15; and it has a dividend yield of 1.69%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is HK$0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 40.42B¥ 41.07B¥ 41.40B¥ 43.95B¥ 39.01B
Gross Profit¥ 20.16B¥ 19.70B¥ 19.68B¥ 20.78B¥ 18.78B
Operating Income¥ 2.54B¥ 4.25B¥ 3.31B¥ 8.30B¥ 6.31B
EBITDA¥ 6.16B¥ 8.60B¥ 7.55B¥ 7.87B¥ 8.70B
Net Income¥ 3.28B¥ 2.77B¥ 2.39B¥ 3.73B¥ 4.73B
Balance Sheet
Cash & Short-Term Investments¥ 15.78B¥ 16.12B¥ 15.58B¥ 17.17B¥ 14.55B
Total Assets¥ 120.07B¥ 117.46B¥ 113.47B¥ 107.16B¥ 93.29B
Total Debt¥ 36.66B¥ 31.70B¥ 30.28B¥ 30.25B¥ 24.25B
Net Debt¥ 23.55B¥ 18.17B¥ 16.59B¥ 14.01B¥ 13.94B
Total Liabilities¥ 58.24B¥ 57.53B¥ 56.85B¥ 53.05B¥ 44.92B
Stockholders' Equity¥ 48.72B¥ 47.26B¥ 45.68B¥ 44.58B¥ 39.19B
Cash Flow
Free Cash Flow¥ 764.78M¥ 66.79M¥ -1.92B¥ -1.67B¥ -1.02B
Operating Cash Flow¥ 5.21B¥ 4.48B¥ 3.41B¥ 4.22B¥ 3.95B
Investing Cash Flow¥ -2.15B¥ -3.61B¥ -3.82B¥ -4.06B¥ -3.86B
Financing Cash Flow¥ -3.24B¥ -1.00B¥ -1.34B¥ 4.43B¥ -831.28M
Currency in CNY

Shanghai Fosun Pharmaceutical (Group) Co Earnings and Revenue History

Income Statement >

Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets

Balance Sheet >

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow

Cash Flow >

Shanghai Fosun Pharmaceutical (Group) Co Forecast EPS vs Actual EPS

Earnings >